FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,106 | -68.0% | 70,815 | 0.0% | 0.01% | -60.0% |
| Q2 2023 | $191,201 | -68.6% | 70,815 | +116.9% | 0.02% | -63.6% |
| Q1 2023 | $609,249 | -32.5% | 32,650 | -52.9% | 0.06% | -21.4% |
| Q3 2022 | $902,000 | +173.3% | 69,347 | +114.7% | 0.07% | +75.0% |
| Q3 2021 | $330,000 | – | 32,299 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 305,784 | $8,143,000 | 8.63% |
| Vantage Consulting Group Inc | 605,713 | $16,130,000 | 2.81% |
| GREAT POINT PARTNERS LLC | 500,000 | $13,315,000 | 2.79% |
| HHLR ADVISORS, LTD. | 3,955,787 | $105,343,000 | 1.08% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $5,094,000 | 1.01% |
| Ikarian Capital, LLC | 250,000 | $6,657,000 | 0.54% |
| BHK Investment Advisors, LLC | 45,100 | $1,201,000 | 0.49% |
| Ikarian Capital, LLC | 193,800 | $5,161,000 | 0.42% |
| Omega Fund Management, LLC | 130,646 | $3,479,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 200,000 | $5,326,000 | 0.36% |